Pharma industry wins significant FDA policy concessions by 2028

By 2028, the pharma industry will secure major concessions from the FDA on drug approval timelines and post-market surveillance requirements. This follows the appointment of a more industry-aligned FDA leadership in 2027.

Implied probability (Yes)

60%